Cure AHC Welcomes Three New Board Members

Cure AHC Welcomes Three New Board Members

Cure AHC is excited to welcome three new high-caliber board members to our Board of Directors. They have already hit the ground running as you will see below:


Simon FrostSimon Frost, CPA (Washington, DC, USA) – Simon and his wife Nina are the parents of Annabel, who has AHC, and Clara her older sister. Simon serves as the Chief Financial Officer at Greencourt Group. He has spent most of his career in real estate investment, operations, and development. Simon holds Bachelor’s and Master’s degrees in Economics from the Cambridge University in the UK, and a Bachelor’s degree in Finance from The University of South Africa. He also holds an active CPA license in Washington DC.- Simon brought us a new Medical Advisory Board member, a deepening understanding of the research landscape, and will attend Rare Disease Week in Washington, DC this February. He also is meeting with our funded research teams at Duke, Columbia, and Aarhus to help us improve on our already highly and effective stewardship of precious donated funds.


Leigh J. Mack, M.DLeigh J. Mack, M.D (Cary, NC, USA) – Dr. Mack is currently the Chief Medical Technology Officer at Crucial Data Solutions, Inc. He is a graduate of USAT Montserrat; holding both MD and PhD degrees. Dr. Mack has post graduate training in Nanotechnology (nanomedicine) from University of Oxford. He trained at John Radcliffe Hospital (University of Oxford/NHS) in Trauma Plastics. Dr. Mack is a Certified Principal Investigator (CPI – ACRP); and a Fellow of the Academy of Physicians in Clinical Research. Recently, became a member of the ACRP Academy Standards Setting Committee for the new CPI exam. Dr. Mack served in the US Army National Guard for 7 years. – Dr. Mack attended a national CRISPR conference held local to him, representing Cure AHC to explore how this cutting-edge technology might be employed in the research efforts for alternating hemiplegia of childhood. He is also finding new members for our Medical Advisory Board, talking with our funded research teams, and helping to put together a 5-year plan to get us to clinical trials using a 3-pronged approach. He will also aim to attend Rare Disease Week. He has several fresh ideas for fundraising and plugging in volunteers


Amr Y. Eissa, M.D. (Saratoga, CA, USA) – Amr is a Johns Hopkins-educated Senior Executive, C-Suite Officer, Entrepreneur, Consultant and Board Member with over 27 years of proven success in tech, biotech, medical device, biopharma and healthcare. Amr has held leadership positions at International Venture Partners/International Consulting Group (Founder/President/CEO) with clients that include Apple, Cisco, Adobe, Symantec, HP, Abbott, Analysis Group, Applied Bio, BioMarin, Celera, Galderma, GSK, InClin, Medivector, Merck, Nektar, Johnson & Johnson, Penumbra, Puma Biotech, St. Jude Medical and Taiho. He is a member of Vistage International, an invitation-only club for successful CEOs, with companies who’s top line revenue is in the $5M to $500M range. In his spare time, Amr enjoys going to the beach with his family and is an avid car racing buff, who along with one of his children, sponsors Camel Jockey Racing! Dr. Eissa is targeting potential major donors from his connections and helping us make contact with other potential partners to facilitate research.

We are grateful for the willingness of our newest members to join the team, and are confident they will make a tremendous positive impact.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search